These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18073314)

  • 21. Effect of continuous thyroxine administration on thyrotropin secretion in thyroidectomized rats.
    Connors JM; Hedge GA
    Endocrinology; 1981 Jun; 108(6):2098-102. PubMed ID: 7227298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
    Geffner DL; Azukizawa M; Hershman JM
    J Clin Invest; 1975 Feb; 55(2):224-9. PubMed ID: 805160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of rat cerebrocortical and adenohypophyseal type II 5'-deiodinase by thyroxine, triiodothyronine, and reverse triiodothyronine.
    Silva JE; Leonard JL
    Endocrinology; 1985 Apr; 116(4):1627-35. PubMed ID: 3971931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 deiodinase Thr92Ala polymorphism is associated with disrupted placental activity but not with dysglycemia or adverse gestational outcomes: a genetic association study.
    Dora JM; Wajner SM; Costa JD; Pinto Ribeiro RV; Leiria LB; Lopes MG; Vitali da Silva A; Crispim D; Maia AL
    Fertil Steril; 2014 Mar; 101(3):833-9. PubMed ID: 24355051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
    Sato T; Ishiguro K; Suzuki Y; Taketani T; Isumisawa A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):385-90. PubMed ID: 816807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.
    Le Moli R; Malandrino P; Russo M; Tumino D; Piticchio T; Naselli A; Rapicavoli V; Belfiore A; Frasca F
    Endocrinol Diabetes Metab; 2023 Mar; 6(2):e406. PubMed ID: 36722311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can the thyrotropin (TSH) suppressive dose of L-thyroxine (T4) be individually predicted in athyroid patients?].
    Kainz H; Weissel M
    Acta Med Austriaca; 1990; 17(2-3):50-4. PubMed ID: 2120901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease.
    Olubowale O; Chadwick DR
    Br J Surg; 2006 Jan; 93(1):57-60. PubMed ID: 16323163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.
    de Jong FJ; Peeters RP; den Heijer T; van der Deure WM; Hofman A; Uitterlinden AG; Visser TJ; Breteler MM
    J Clin Endocrinol Metab; 2007 Feb; 92(2):636-40. PubMed ID: 17105838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence and regulation of D1 and D2 deiodinases in rat white adipose tissue.
    Calvo RM; Obregon MJ
    Metabolism; 2011 Sep; 60(9):1207-10. PubMed ID: 21397282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters.
    Peeters RP; van den Beld AW; Attalki H; Toor Hv; de Rijke YB; Kuiper GG; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E75-81. PubMed ID: 15727947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.
    Sato T; Suzuki Y; Taketani T; Ishiguro K; Nakajima H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):553-9. PubMed ID: 402383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression.
    Brouwer JP; Appelhof BC; Peeters RP; Hoogendijk WJ; Huyser J; Schene AH; Tijssen JG; Van Dyck R; Visser TJ; Wiersinga WM; Fliers E
    Eur J Endocrinol; 2006 Jun; 154(6):819-25. PubMed ID: 16728541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.
    Diano S; Naftolin F; Goglia F; Horvath TL
    Endocrinology; 1998 Jun; 139(6):2879-84. PubMed ID: 9607797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.